hipofiza final
TRANSCRIPT
-
7/23/2019 Hipofiza Final
1/17
,
- .
, , .
! , , ,
.
! , "
# $ %.
#, # ,
.
'
(. , ,
$ %). - , , ,
.*. , , ,
".
#
$*%, $)%
$%.
3
-
7/23/2019 Hipofiza Final
2/17
-Glandula pituitaria
" $hypophysis%
, #
. + " ,
$hypothalamus), ! " $diencephalon%.
" , - !
- . /
fossa hypophysialis, $sella turcica), 0
" $os sphenoidale%.
/ , #0 $tuber
cinereum%, " $infundibulum/pedunculus infundibularis%. Tuber cinereum
",
$chiasma opticum% # $corpora mammillaria%. 1 0 0 0 eminentia mediana. &"
0 ". # "
$tractus supraopticohypophysialis% " , .
2 , " " "
0, 0, " 0 ".
1 $diaphragma sellae
turcicae%, # 0 ".
4
-
7/23/2019 Hipofiza Final
3/17
3 " " (4, (5
6. 7 5,8. 9" 4:8 "
0 $pars anterior%, 0 $pars intermedia% 0 $pars infundibularis% ,
" # ;;>?=@ @, " 0
" $pars nervosa%.
9" # B8C ", 0 $pars anterior -
distalis%, 0 $pars intermedia% 0 $pars infundibularis - tuberalis% . D
" . /
", , E $Rathke% ,
! .
" # #
# , # ,
, , . F # 0
, #
".
5
-
7/23/2019 Hipofiza Final
4/17
3 ". D , ,
. $%,
. &! 0 , ,
.
2 # 0, "
' " $85C%, " $45C% " $(5C%. "
$chromosGphobia- % # , ,
, . 9" "
0 . H" #
, " . 9" " " $chromos- Gphilein- %.
!"
"
, " " . 2
" 0 ,
. + "
. "# "
#. & # .
9" , "
, . /
, # , ,
, #, , . 1
$% "
, # . I "
, #
# JK .
6
-
7/23/2019 Hipofiza Final
5/17
D $LMN% ! . & 0
, , . J
# #, , ! . 1
$LMN%.
# ", # , ,
, . /
" OPQ ( $ # " (% , . # #
, . D0
LMN .
+ $, RMN %
. I . 9
0, # . D
0 , #
" ". + $RMN% # # .
7 $MLN% 0 . & ,
# . D ,
, ! " . / #
$ MLN%, .
J $QLN:RN% ". &
. D , 0 . 1
' " $QLN%
$SRN%. QLN " $0
"%, . RN # ,
$corpus luteum% 0 ,
S ,
$OTLN%.
F $UTMN% ,
# . J , " ,
"
", " . / #
$UTMN%, .
# !"
7
-
7/23/2019 Hipofiza Final
6/17
" # 85C ". D
" . 2 #
0 0 . 1 "
"
, " # $% .
V # 8C ".
# ! ,
. D #
" " .
" . +!
. "
$PQUW%. D "
.
+# $% . &
. X " ".
$%# "
"
". / " . 7
$ " %, !
! . 3 ",
UTMN, QLN = RN. 1
, 0 .
W@YZ =>?;Y
-
7/23/2019 Hipofiza Final
7/17
UTMN \LN
$W]\T%.
&%
2" , [2D-
. / " '
$pars nervosa=^= lobus nervosus%, " $infundibulum%, 0
0 $eminentia mediana%.
&' $pars nervosa)
W@YZ >;Y_`Z@ " !
. &!
$%, # # $nucleus supraopticus%
$nucleus paraventricularis% .
" ,
", " .
1 0 " (55.555 . / " -" $NNM%.
9 NNM - "# '
(. ,
, 2.
.
9
-
7/23/2019 Hipofiza Final
8/17
I 7- ,
0 . 2
, ,
". 1
, $% .
3 # 0
" , # 85 a, $Herring% .
2 (5-*5 a, . 1
0 $ ADH%.
/ , UbN #
.
/ !
0.
10
-
7/23/2019 Hipofiza Final
9/17
9 #'
(. 0 0 0 $0
%, ). .
c . ,
UMW ", . 7
. 2
" " .
. I
# 0. & 0 " .
! . , +
", ! PQUW-.
D "# .
11
-
7/23/2019 Hipofiza Final
10/17
(%#%% )"
(%#%% *p+dun,ulu in.undi/ulari0
&" 0 " . D
-" !
".
)"
0 " #
. / ",
NNM- NOM- " tanicite.
7 ,
, 0 ! .
1%)"
" "# "
! ,
".
d 0 0 " , 0
$a. carotis interna).
J0 " 0 , ",e@YZ ?fg;Y@^=Z,
# pars intermedia.
12
-
7/23/2019 Hipofiza Final
11/17
.
1 " " , $ %. 1
, !
-" . /
. / 0 "
", , ,
.
1 "
" # ,
" " . 3 # -"
.
30 " 0 0 ". F
" " " ,
0 .
13
-
7/23/2019 Hipofiza Final
12/17
- '
" " K
# ". (C ,
!,
, , " # , ,
, 0, .
3 -"
". 7 # # $%.
1 nucleus supraopticus nucleus paraventricularis,
# . 1 0 #
" -" $-" %. /
! . 1 0
, 0
".
3 # . 1 0 #
", " -
" $-" %. /
. 2
$%, . /
". 2
! $. releasing% . /
, , .
& .
14
-
7/23/2019 Hipofiza Final
13/17
1 ! " - $LNhN%,
- $MhN%, . $PhN%
- $ThN%. 1
. D ,
. / "
, # 0
, . I "
0
#
.
2 3 4' "'
$ STH% 0
0 #, ".
9 $ACTH% #0
# , # .
15
-
7/23/2019 Hipofiza Final
14/17
7 $TSH) ,
#0 ,
.
$PRL% # 0 .
3 , " $FSH%
$LH%, 0
.
9 $ADH% #0
#.
/ $OX% 0
0 !0 .
'4
16
-
7/23/2019 Hipofiza Final
15/17
D " #
" $[7% $2+E%. 1
0 , 0 #
0 .. .
"2+E , #0, " # +E 0.
+ , "
# 2+E "
.
5%)" '4
D !0
" . X !0 # 0 "
" #0 0 . 7
" " !0
, 0 0 .
7 0 -"-" $d%, # "
", "
d .
D 0 ,
0 !0 0
, ".
17
-
7/23/2019 Hipofiza Final
16/17
E " !0
, #0 " $%
! . # #
- # .
+0 !0 [,
0 , !0
. D
, . 2#
!0 [
'
(. " 0 ",
). !0
[, 0 0
0, *. 0 ".
1 #0 D7 0
", 0 i,
((, (* (i #.
/!0 0 ,
# , !0 #
. 3 !0
# # " 0
" ".
18
-
7/23/2019 Hipofiza Final
17/17
V 0 " 0
. 2# ! $0 !0
0 "# %.
/ # #
" .
19